PTU - Polskie Towarzystwo Urologiczne
list of articles:

ORCHIDECTOMY VALUE IN THE TREATMENT OF OESTROGEN-RESISTANT PROSTATIC NEOPLASMS
Article published in Urologia Polska 1985/38/2.

authors

Leszek Jaromin, Janina Szymańska, Marek Rożniecki
Z Kliniki Urologii Instytutu Chirurgii AM w Łodzi Kierownik Kliniki: doc. dr hab. med. L. Jeromin

summary

The authors report their observations from a period of ten years concerning the treatment of oestrogen-resistant prostatic neoplasma in 31 patients in whom orchidectomy was done decause of deteriorating general condition and urinary re­tention. In 25 cases the patients improved, and in 7 cases spontaneous bladder voiding became again possible. ,In 24 cases transurethral prostatic electroresection was re±uired. Secondary orchidectomy improved the general condition of most patients but had no effect on the progression of prostatic tumour.

references

  1. 1. Blackard C. E., Doe R. P., Mellinger G. T., Byar D. P.: Incidens of cardio-
  2. vascular disease and death in patients reaceiving diethylstilbestiol for carcinoma
  3. of the prostatae. Cancer, 1970, ,26, 249. ? 2. Blacklock N. J.: Prostatic cancer. Urol.
  4. Res., 1977, 5, 1. ? 3. Ghisholm G. D., O'Donoghue E. P. N., Kennedy C. L.. The
  5. treatment of oestrogen-escaped carcinoma of the (prostate with estramustine phos­
  6. phate. Brit. J. Urol., 1977, 49, 717. ? 4. Davies C, Jacobi J., Lloyd H. M., Meares
  7. J. D.: DNA synthesis and the secretion of Prolactin and growth hormone by the
  8. pituitary gland of the male rat: effects of diethylsilboestrol and 2-bromo-alfa-ergo-
  9. cniptine rnethanesulphonate. J. Endocr., 1974, 61, 411. ? 5. Fossa S. D., Fossa J.,
  10. Aakvaag A.: Hormone changes in patients with prostatic carcinoma during treat­
  11. ment with estramustine phosphate. J. Urol., 1977, 118, 1913. ? 6. Hachmeister U.:
  12. Hyperplasia of Prolactin cells after estrogen therapy in carcinoma of the prostate.
  13. Verh. Dt. Ges. Path., 1972, 56, 535. ? 7. Ishibe T.: Effect of long term estrogen
  14. treatment on liver function in patients with prostatic carcinoma. J. Urol., 1975,
  15. 1.13, 829. ? 8. Ishibe T., Usui T., Nihira H.: Prostatic value of liver function tests
  16. in carcinoma of the prostate. Urol. Int., 1976, 31, 205. ? 9. luman W. H. W., Ves-
  17. sey M. P., Westerholm B., Engelund A.: Tromboembolic disease and the steroidol
  18. content of oral contraceptive:s. A report to the Committee on Safety of Drugs. Brit.
  19. Med. J., 1970, 2, 203. ? 10. Jacobi G. H, Altwein J. E.: Bromocriptine, ein neues
  20. thearapeutische Rrioziip ibeSim Postate-Adeinom und Karaimom. Dt. med. Wschr.,
  21. 1978, 103, 827.
  22. 11I. Jeromin L.: Testosteronie and Prolactin levels in the serum patients with
  23. carcinoma of the prostatae treated verious doses of fostrolin and bromocriptin.
  24. Int. Urol. Nephrol., 19:82, 14, 51. ? 12. Jeromin L., Prelich A.: Własne do¶wiadcze­
  25. nia w leczeniu estracytem estrogeno-opornych nowotworów stercza. Urol. Pol.,
  26. 1982, 3?4, 209. ? 13. Jeromin L.: Znaczenie prolaktyny we wzro¶cie nowotworów
  27. stercza. Pol. Tyg. Dek., 1980, 35, 453. ? 14. Jeromin L.: Zastosowanie bromokryp­
  28. tyny w leczeniu raka stercza. Urol. Pol., 1982, 3?4, 141. ? 15. Jeromin L.: Meta­
  29. bolizm testosteronu w raku stercza. Urol. Pol., 1982, 3?4, 135. ? 16. Mazurek L:
  30. Ksi±żka pod redakcj± Zieliński J.: Onkologia Urologiczna. PZWL, Warszawa, 1977. ?
  31. 17. Resnick M. I., Grayhack J. T: Effect of 2-bromo-alfa-ergocriptine (CB-154) on
  32. estrogen induced growth of the rat prostate. Invest. Urol., 1978, 15, 392. ? 18. Sau-
  33. ford E. J., Paulson D. F., Rohner T.J., Drago J. R., Sauten R. J., Bardini C. W.:
  34. The effects of castration on adrenal testosterone secretion in men with prostatic
  35. carcinoma. J. Urol., 1977, 118, 1019. ? 19. Straube W., Braun J. S.: Zur Orchidekto­
  36. mie und Oestrogentherapie des Prostatakarzinams. Urologe A., 1974, 13, 198. ? 20.
  37. The Veterans Administration Cooperative Urological Research Group: Treatment
  38. and survival of patients with cancer of the prostate. Surg. Gynec. Obstet., 1967,
  39. 124, 1011.